American International Group, Inc. Seres Therapeutics, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 48,475 shares of MCRB stock, worth $34,902. This represents 0.0% of its overall portfolio holdings.

Number of Shares

48,475

Previous 48,352 0.25%

Holding current value

$34,902

Previous $67,000 44.78%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.75 - $1.56 $92 - $191	123 Added 0.25%	48,475 $37,000
Q4 2023 Feb 13, 2024	SELL	$0.93 - $2.15 $180 - $417	-194 Reduced 0.4%	48,352 $67,000
Q3 2023 Nov 13, 2023	BUY	$2.33 - $5.07 $4,021 - $8,750	1,726 Added 3.69%	48,546 $115,000
Q2 2023 Aug 04, 2023	BUY	$4.67 - $6.55 $59,841 - $83,931	12,814 Added 37.68%	46,820 $224,000
Q1 2023 May 12, 2023	BUY	$4.95 - $6.09 $3,346 - $4,116	676 Added 2.03%	34,006 $192,000

Q4 2022 Feb 10, 2023	SELL	$5.09 - $9.05 $615 - $1,095	-121 Reduced 0.36%	33,330 $186,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $1,655 - $3,405	473 Added 1.43%	33,451 $215,000
Q2 2022 Aug 12, 2022	SELL	$2.7 - $7.62 $4,255 - $12,009	-1,576 Reduced 4.56%	32,978 $113,000
Q1 2022 May 13, 2022	SELL	$6.3 - $8.84 $15,334 - $21,516	-2,434 Reduced 6.58%	34,554 $246,000
Q4 2021 Feb 11, 2022	SELL	$6.02 - $11.43 $6,658 - $12,641	-1,106 Reduced 2.9%	36,988 $308,000
Q3 2021 Nov 12, 2021	SELL	$5.46 - $22.6 $4,941 - $20,453	-905 Reduced 2.32%	38,094 $265,000
Q2 2021 Aug 13, 2021	BUY	$18.46 - $24.36 $125,675 - $165,842	6,808 Added 21.15%	38,999 $930,000
Q1 2021 May 07, 2021	BUY	$17.66 - $28.92 $1,518 - $2,487	86 Added 0.27%	32,191 $663,000
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $8,300 - $13,469	357 Added 1.12%	32,105 $787,000
Q3 2020 Nov 04, 2020	BUY	$3.74 - $28.74 $18,228 - $140,078	4,874 Added 18.14%	31,748 $899,000
Q2 2020 Aug 12, 2020	BUY	$3.04 - $6.2 $16,048 - $32,729	5,279 Added 24.45%	26,874 $128,000
Q1 2020 May 04, 2020	SELL	$2.64 - $3.82 $3,294 - $4,767	-1,248 Reduced 5.46%	21,595 $77,000
Q4 2019 Feb 05, 2020	SELL	$2.99 - $4.42 $574 - $848	-192 Reduced 0.83%	22,843 $79,000
Q3 2019 Nov 08, 2019	BUY	$2.29 - $4.16 $21,528 - $39,108	9,401 Added 68.95%	23,035 $92,000
Q2 2019 Aug 13, 2019	BUY	$2.28 - $7.35 $1,146 - $3,697	503 Added 3.83%	13,634 $44,000
Q1 2019 May 06, 2019	SELL	$4.83 - $7.21 $2,047 - $3,057	-424 Reduced 3.13%	13,131 $90,000
Q4 2018 Feb 13, 2019	SELL	$4.52 - $8.88 $474 - $932	-105 Reduced 0.77%	13,555 $61,000
Q3 2018 Nov 09, 2018	BUY	$7.33 - $9.23 $1,803 - $2,270	246 Added 1.83%	13,660 $104,000
Q2 2018 Aug 08, 2018	BUY	$6.91 - $9.55 $2,356 - $3,256	341 Added 2.61%	13,414 $115,000
Q1 2018 May 07, 2018	SELL	$7.34 - $11.16 $5,167 - $7,856	-704 Reduced 5.11%	13,073 $96,000
Q4 2017 Feb 09, 2018	BUY	$9.15 - $12.64 $594 - $821	65 Added 0.47%	13,777 $140,000
Q3 2017 Nov 09, 2017	BUY	$12.81 - $16.85 $175,650 - $231,047	13,712	13,712 $220,000

Others Institutions Holding MCRB

# of Institutions

100

Shares Held

62.7M

Call Options Held

36.9K

Put Options Held

476K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Seres Therapeutics, Inc. Transaction History